USPTO serial 79128394
Reviewed by CopyMark Law Group
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Nancy Sabarra
Nancy Sabarra Fross Zelnick Lehrman & Zissu, P.C.151 West 42nd St., 17th Fl.New York, NY 10036UNITED STATES| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical preparations and substances for the treatment and/or prevention of blood or bleeding disorders; vaccines; blood products in this class, namely, blood plasma, reagent blood cells; products derived from blood and products derived from recombinant DNA technology, namely, immunoglobulins, human albumin, blood clotting factors, plasma volume expanders, blood proteins for therapeutic use; serums, namely, anti-venoms; medicated serums for the treatment of blood or bleeding disorders; test kits in the class, namely, invitro diagnostic reagent test kits for use in detecting cell mediated immune response; pharmaceutical preparations and substances, namely, RhD reagents for the detection of specific antigens or in blood typing; pharmaceutical preparations, namely, reagent red blood cells used to detect antibodies or IgG subtypes; pharmaceutical preparations, namely, monoclonal and polyclonal antibodies ; pharmaceutical preparations, namely, reagents for medical/clinical use for the typing and detection of specific blood cells, and the detection of relevant compliment components and immunoglobulin subtypes | SECTION 71 - CANCELLED | — |
| 010 | Surgical and medical apparatus and instruments for use in intravenous administration of pharmaceutical and blood products for the treatment of blood or bleeding disorders and vaccines; analysis apparatus and instruments in this class, namely, apparatus for blood analysis | SECTION 71 - CANCELLED | — |
| 044 | Medical services; providing medical information concerning blood products; providing medical information concerning vaccines, anti-venoms and immunohaematology products, namely, diagnostic reagents; patient support services, namely, providing an Internet-based database of patient medical information where patients can enquire about medical issues and procedures from other patients and can relay information about their medical experiences for support and community | SECTION 71 - CANCELLED | — |
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
| Date | Code | Event | What it means |
|---|---|---|---|
| Jul 9, 2023 | DENC | NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED | — |
| Jul 9, 2023 | DETH | DEATH OF INTERNATIONAL REGISTRATION | — |
| Mar 6, 2022 | INNT | TOTAL INVALIDATION PROCESSED BY THE IB | — |
| Feb 11, 2022 | INTS | TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB | — |
| Feb 11, 2022 | INPC | INVALIDATION PROCESSED | — |
| Oct 26, 2021 | INTR | TOTAL INVALIDATION OF REG EXT PROTECTION CREATED | — |
| Feb 26, 2021 | C71T | CANCELLED SECTION 71 | — |
| Nov 25, 2019 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Nov 25, 2019 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Mar 11, 2019 | REM3 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | — |
| Dec 17, 2018 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Dec 17, 2018 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Jul 27, 2017 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| May 18, 2017 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Feb 10, 2017 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Dec 16, 2016 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Jul 1, 2016 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jul 1, 2016 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Jul 22, 2014 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Jun 23, 2014 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Jun 23, 2014 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Jun 11, 2014 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Mar 11, 2014 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Dec 24, 2013 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Dec 24, 2013 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Dec 24, 2013 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Dec 4, 2013 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Dec 4, 2013 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Dec 4, 2013 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Nov 18, 2013 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Nov 13, 2013 | ALIE | ASSIGNED TO LIE | — |
| Oct 25, 2013 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Oct 24, 2013 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Oct 24, 2013 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Oct 24, 2013 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Oct 18, 2013 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Oct 18, 2013 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| May 26, 2013 | RFNT | REFUSAL PROCESSED BY IB | — |
| May 3, 2013 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| May 3, 2013 | RFRR | REFUSAL PROCESSED BY MPU | — |
| May 3, 2013 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| May 2, 2013 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 30, 2013 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Apr 26, 2013 | DOCK | ASSIGNED TO EXAMINER | — |
| Apr 26, 2013 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Apr 25, 2013 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |